Dr George Owiti, a radiographer at Kericho County Hospital examines the Chest CT results of a patient admitted to the hospital. [James Wanzala, Standard] Despite recent breakthroughs that have ...
A PET radiotracer that can visualize deep vein thrombosis and pulmonary embolism wins the Society of Nuclear Medicine and ...
PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...
Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.
PET/CT scans are crucial for staging, treatment response monitoring, and detecting extramedullary disease in multiple myeloma patients undergoing CAR T-cell therapy. Bone-independent extramedullary ...
A PET scan can help doctors spot cancer that has spread through the body. A doctor may request one during the melanoma diagnostic process if they suspect advanced melanoma cancer. A PET scan is an ...
Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.
A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.
A newly developed portable, point-of-care PET technology can image any organ, delivering high-quality results to guide ...
PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...
Hosted on MSN
Foods to Eat and Foods to Avoid Before a PET Scan
A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.
A blood test following CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL) appears to do a better job than PET-CT scans at predicting which patients have poor prognoses, a small, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results